Omninext provides business consulting and digital solutions, working with both private and public enterprises to enhance their potential through specialized and interconnected digital solutions.

Omninext

H.U. Group Holdings, Inc., through its subsidiaries, provides laboratory testing products and services in Japan. The company offers lab testing and its related services to medical institutions; self-medication services; food, environment, and cosmetic testing services; and testing services through corporate health insurance associations. It also researches, develops, manufactures, and sells in vitro diagnostic devices, which includes the LUMIPULSE, an automatic chemiluminescent enzyme immunoassay system that offers reagents for infectious disease, cancer, and lifestyle disease to medical institutions and testing centers; and ESPRINE, a rapid diagnostics kit series for influenza, hepatitis B, and the novel coronavirus, as well as supplies ingredients for test drugs. In addition, the company provides support services related to hospital administration work, including aid for surgical procedures and endoscope room work, inspection and maintenance services for medical equipment, and in-hospital logistics management and transportation services; and rents and sells nursing-care equipment and supplies. Further, it offers home-visit nursing care services. The company was formerly known as Miraca Holdings Inc. and changed its name to H.U. Group Holdings, Inc. in July 2020. H.U. Group Holdings, Inc. was incorporated in 1950 and is headquartered in Tokyo, Japan.

H.U. Group Holdings, Inc.

OMRON is engaged in the field of industrial automation, healthcare, social systems, device and module solutions, and data solutions, providing various technologies and products to improve societal infrastructure and personal health.

OMRON

PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devices, as well as data linkage solutions; anatomical pathology solutions, such as instruments, microscope slides, and dyeing reagents; and equipment and services for various sample preservation and cell culture in the life sciences field. It also provides healthcare IT products in the field of medical information systems for clinics and healthcare insurance pharmacies. In addition, the company engages in clinical testing, diagnostic reagents, and drug development support businesses. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. The company was founded in 2014 and is headquartered in Tokyo, Japan.

Metric
Company Name	Omninext	H.U. Group Holdings, Inc.	OMRON	PHC Holdings Corporation
Symbol		4.54K		6.52K
MSH ID	IT:OMNINEXT	COM:HUGP	COM:OMRON	COM:PHCHD
Market	PRIVATE	STOCKS	STOCKS	STOCKS
Sector	Commercial & Professional Services	Healthcare	Technology	Healthcare
Industry	Information Technology	Medical - Diagnostics & Research	Industrial Automation & Healthcare	Medical - Devices
Country	IT	JP	JP	JP
Stage
Employee Count		5.29K		9.24K
Website	omninext.it	hugp.com	omron.com	phchd.com/jp
LinkedIn
Founders

Metric
Market Cap		917.59M	7.13B	958.06M
Enterprise Value
Monthly Web Traffic	741
Web Traffic Growth	0.09
Valuation
Raised Capital

Metric
Revenue	1.58B	2.36B
Revenue (LTM)
Revenue (NTM)
Gross Profit	381.91M	932.50M
EBITDA	112.22M	241.73M
Operating Income	-26.97M	55.44M
Net Income	-50.37M	-85.98M
EPS	-0.89	-0.68
Diluted EPS	-0.89	-0.68
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin	0.28	0.45
Operating Profit Margin	-0.01	-0.00
EBITDA Margin	0.07	0.10
Net Profit Margin	-0.03	-0.04
Return on Equity	-0.04	-0.09
Return on Assets	-0.02	-0.02
Return on Capital Employed	-0.01	-0.00

OMNI

IT:OMNINEXT

Omninext

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio	-93.20	-27.73
P/B Ratio	1.05	1.29
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio	0.65	0.47
EV Multiple	7.05	-3.15

Metric
Days Sales Outstanding	72.67	65.90
Days Payables Outstanding	36.90	125.77
Days Inventory Outstanding	50.32	108.74
Operating Cycle	122.36	175.35
Cash Conversion Cycle	81.16	51.28
Asset Turnover	0.84	0.64

Metric
Operating Cash Flow	110.38M	275.47M
Free Cash Flow	-6.71M	177.90M
Cash Flow to Debt	0.36	0.15
Operating Cash Flow/Sales	0.10	0.12
Free Cash Flow Yield	0.03	0.14

Metric
Cash & Equivalents	266.42M	313.75M
Accounts Receivable	4.27M	20.42M
Inventory	149.80M	351.15M
Goodwill	49.35M	1.39B
Debt to Capitalization	0.34	0.70
Debt to Assets	0.22	0.51
Current Ratio	2.43	1.44
Quick Ratio	1.57	0.92

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue				0.40